Karyopharm Therapeutics GAAP EPS of -$3.82 misses by $0.30, revenue of $44.04M beats by $1.63M (NASDAQ:KPTI)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...